NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ObvioHealth

ObvioHealth

Private
New York City, New YorkHealthcare & Life Scienceshttps://obviohealth.com

Last Round

Series B

Extension

Jul 25, 2024

Total Funding Raised

$69.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ObvioHealth is a healthcare technology company that provides an end-to-end virtual research organization (VRO) platform designed to facilitate decentralized and hybrid clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

decentralized clinical trialsDCTremote patient monitoringdigital clinical trialseConsentclinical trial managementvirtual trialshybrid clinical trialsreal-time data collectionpatient recruitmentclinical research softwareeCOAsite-less trialsclinical trial platformclinical trial automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ObvioHealth Comps

Public and private peers based on sector, stage, and business model.

ObvioHealth comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ObvioHealth Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJul 25, 2024
Series BJul 1, 2021
Series AMay 20, 2020
SeedMar 23, 2018

Key People

Founding team and executive leadership

Ivan Jarry

Chief Executive Officer

Executive Team

ObvioHealth Investors

Notable investors and investment history

ObvioHealth investors
InvestorRounds
Tikehau CapitalSeed
SPRIM Global InvestmentsSeed, Series A, Series B
Tikehau Investment ManagementSeed
AT Capital GroupSeries B
SPRIM Global InvestmentsSeries B, Seed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 24, 2026

    Novotech Group selected ObvioGo platform for multi-trial license.

  • Jul 7, 2025

    Added PhRMA, a pharmaceutical trade association, as a customer.

ObvioHealth Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ObvioHealth Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ObvioHealth's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range63
Year Founded2015
Last FundingJul 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.